OR | 95% CI | ||
Drug adherence (MPR ≥ 80) | |||
Region | |||
Seoul | 1.242 | 1.207 | 1.278 |
Gyeonggi-do | 1.147 | 1.115 | 1.180 |
Metropolitan | 1.000 | – | – |
Chungcheon-do | 0.963 | 0.926 | 1.001 |
Jeolla-do | 0.900 | 0.865 | 0.935 |
Gangwon-do | 1.058 | 1.003 | 1.117 |
Gyeongsang-do | 0.935 | 0.905 | 0.967 |
Income | |||
Low | 0.918 | 0.897 | 0.940 |
Low-moderate | 0.925 | 0.901 | 0.950 |
Moderate-high | 0.948 | 0.927 | 0.970 |
High | 1.000 | – | – |
Estimate | SE | p-value | |
Defined daily dose (statin) | |||
Region | |||
Seoul | 10.318 | 0.833 | < 0.0001 |
Gyeonggi-do | 6.734 | 0.827 | < 0.0001 |
Metropolitan | 1.000 | – | – |
Chungcheon-do | −4.609 | 1.157 | < 0.0001 |
Jeolla-do | −4.676 | 1.075 | < 0.0001 |
Gangwon-do | 6.469 | 1.662 | < 0.0001 |
Gyeongsang-do | −4.583 | 0.921 | < 0.0001 |
Income | |||
Low | −3.894 | 0.696 | < 0.0001 |
Low-moderate | −3.166 | 0.748 | < 0.0001 |
Moderate-high | −1.320 | 0.652 | 0.0427 |
High | 1.000 | – | – |